CIBC Bancorp USA’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.2M Buy
101,839
+93,261
+1,087% +$15.2M 0.02% 421
2026
Q2
$1.29M Buy
8,578
+402
+5% +$43.7K ﹤0.01% 1035
2026
Q1
$755K Buy
+8,176
New +$821K ﹤0.01% 1111
2025
Q3
$796K Buy
+12,734
New +$693K ﹤0.01% 722

Other funds holding GH

CIBC Bancorp USA's GH Position: Q3 2026 in Review

CIBC Bancorp USA increased its Guardant Health (GH) stake by 1,087% in Q3 2026, buying an estimated $15.2M and bringing the position to 101,839 shares worth $18.2M. The position accounts for 0.02% of the portfolio, ranked #421.

CIBC Bancorp USA first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • CIBC Bancorp USA held 101,839 shares of Guardant Health worth $18.2M as of Q3 2026.
  • CIBC Bancorp USA bought 93,261 Guardant Health shares in Q3 2026, an estimated $15.2M.
  • Guardant Health made up 0.02% of CIBC Bancorp USA's portfolio in Q3 2026, its #421 holding.
  • CIBC Bancorp USA first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.